1. Home
  2. EXEL vs AA Comparison

EXEL vs AA Comparison

Compare EXEL & AA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • AA
  • Stock Information
  • Founded
  • EXEL 1994
  • AA 1888
  • Country
  • EXEL United States
  • AA United States
  • Employees
  • EXEL N/A
  • AA N/A
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • AA Aluminum
  • Sector
  • EXEL Health Care
  • AA Industrials
  • Exchange
  • EXEL Nasdaq
  • AA Nasdaq
  • Market Cap
  • EXEL 10.4B
  • AA 10.4B
  • IPO Year
  • EXEL 2000
  • AA 2016
  • Fundamental
  • Price
  • EXEL $38.94
  • AA $36.76
  • Analyst Decision
  • EXEL Buy
  • AA Buy
  • Analyst Count
  • EXEL 22
  • AA 11
  • Target Price
  • EXEL $44.10
  • AA $37.41
  • AVG Volume (30 Days)
  • EXEL 2.9M
  • AA 8.4M
  • Earning Date
  • EXEL 11-04-2025
  • AA 10-22-2025
  • Dividend Yield
  • EXEL N/A
  • AA 1.09%
  • EPS Growth
  • EXEL 81.76
  • AA N/A
  • EPS
  • EXEL 2.08
  • AA 4.31
  • Revenue
  • EXEL $2,230,005,000.00
  • AA $12,868,000,000.00
  • Revenue This Year
  • EXEL $9.14
  • AA $9.45
  • Revenue Next Year
  • EXEL $12.59
  • AA $0.58
  • P/E Ratio
  • EXEL $18.75
  • AA $8.53
  • Revenue Growth
  • EXEL 10.73
  • AA 16.94
  • 52 Week Low
  • EXEL $31.18
  • AA $21.53
  • 52 Week High
  • EXEL $49.62
  • AA $47.77
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 50.54
  • AA 51.27
  • Support Level
  • EXEL $33.76
  • AA $35.64
  • Resistance Level
  • EXEL $40.63
  • AA $40.00
  • Average True Range (ATR)
  • EXEL 1.30
  • AA 1.73
  • MACD
  • EXEL 0.17
  • AA -0.07
  • Stochastic Oscillator
  • EXEL 75.47
  • AA 25.39

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About AA Alcoa Corporation

Alcoa is a vertically integrated aluminum company whose operations include bauxite mining, alumina refining, and manufacturing primary aluminum. It is the world's largest bauxite miner and alumina refiner by production volume, and the eighth-largest aluminum producer. Profits are closely tied to prevailing commodity prices along the aluminum supply chain.Alcoa was the first mass producer of aluminum, launching the world-changing Hall-Heroult smelting process in the 1880s, making aluminum affordable. It listed as a public company in 1925. In 2016, Alcoa spun off its automotive and aerospace metal parts segment to focus on mining, smelting, and refining. It bought the 40% unowned balance of AWAC in mid-2024, meaning refining assets are now predominantly wholly owned, as with smelting.

Share on Social Networks: